Bank of New York Mellon’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14M | Buy |
246,485
+29,259
| +13% | +$1.3M | ﹤0.01% | 1843 |
|
|
2026
Q1 | $6.45M | Sell |
217,226
-2,770
| -1% | -$82.8K | ﹤0.01% | 2176 |
|
|
2025
Q4 | $8.41M | Sell |
219,996
-17,247
| -7% | -$561K | ﹤0.01% | 2029 |
|
|
2025
Q3 | $5.67M | Buy |
237,243
+6,098
| +3% | +$115K | ﹤0.01% | 2242 |
|
|
2025
Q2 | $3.42M | Sell |
231,145
-2,797
| -1% | -$46.4K | ﹤0.01% | 2484 |
|
|
2025
Q1 | $4.19M | Buy |
233,942
+17,079
| +8% | +$347K | ﹤0.01% | 2316 |
|
|
2024
Q4 | $3.78M | Buy |
216,863
+7,513
| +4% | +$133K | ﹤0.01% | 2433 |
|
|
2024
Q3 | $2.93M | Sell |
209,350
-55,466
| -21% | -$578K | ﹤0.01% | 2571 |
|
|
2024
Q2 | $2.18M | Buy |
264,816
+41,048
| +18% | +$276K | ﹤0.01% | 2749 |
|
|
2024
Q1 | $1.73M | Sell |
223,768
-14,232
| -6% | -$120K | ﹤0.01% | 2839 |
|
|
2023
Q4 | $2.14M | Sell |
238,000
-7,978
| -3% | -$58.1K | ﹤0.01% | 2799 |
|
|
2023
Q3 | $2.2M | Sell |
245,978
-2,168
| -0.9% | -$30.6K | ﹤0.01% | 2760 |
|
|
2023
Q2 | $3.81M | Buy |
248,146
+31,377
| +14% | +$571K | ﹤0.01% | 2470 |
|
|
2023
Q1 | $4.88M | Buy |
216,769
+3,546
| +2% | +$75.4K | ﹤0.01% | 2310 |
|
|
2022
Q4 | $4.48M | Sell |
213,223
-895
| -0.4% | -$19K | ﹤0.01% | 2399 |
|
|
2022
Q3 | $5.28M | Buy |
214,118
+23,617
| +12% | +$610K | ﹤0.01% | 2265 |
|
|
2022
Q2 | $4.62M | Sell |
190,501
-30,286
| -14% | -$762K | ﹤0.01% | 2359 |
|
|
2022
Q1 | $5.69M | Sell |
220,787
-1,301
| -0.6% | -$34.5K | ﹤0.01% | 2352 |
|
|
2021
Q4 | $6.89M | Sell |
222,088
-1,162
| -0.5% | -$32.7K | ﹤0.01% | 2294 |
|
|
2021
Q3 | $5.41M | Buy |
223,250
+19,796
| +10% | +$364K | ﹤0.01% | 2447 |
|
|
2021
Q2 | $2.97M | Sell |
203,454
-2,958
| -1% | -$58.3K | ﹤0.01% | 2756 |
|
|
2021
Q1 | $5.15M | Buy |
206,412
+10,723
| +5% | +$296K | ﹤0.01% | 2438 |
|
|
2020
Q4 | $5.33M | Buy |
195,689
+4,112
| +2% | +$96K | ﹤0.01% | 2327 |
|
|
2020
Q3 | $3.54M | Buy |
191,577
+10,632
| +6% | +$207K | ﹤0.01% | 2399 |
|
|
2020
Q2 | $3.69M | Sell |
180,945
-5,847
| -3% | -$93.1K | ﹤0.01% | 2359 |
|
|
2020
Q1 | $2.73M | Buy |
186,792
+47
| +0% | +$707 | ﹤0.01% | 2387 |
|
|
2019
Q4 | $2.65M | Buy |
186,745
+6,208
| +3% | +$79.3K | ﹤0.01% | 2649 |
|
|
2019
Q3 | $2.09M | Buy |
180,537
+2,272
| +1% | +$37.5K | ﹤0.01% | 2737 |
|
|
2019
Q2 | $3.58M | Sell |
178,265
-2,461
| -1% | -$48.6K | ﹤0.01% | 2496 |
|
|
2019
Q1 | $4.09M | Buy |
180,726
+2,697
| +2% | +$59.6K | ﹤0.01% | 2432 |
|
|
2018
Q4 | $4.03M | Sell |
178,029
-180,708
| -50% | -$4.5M | ﹤0.01% | 2421 |
|
|
2018
Q3 | $10.3M | Sell |
358,737
-3,286
| -0.9% | -$93.9K | ﹤0.01% | 2011 |
|
|
2018
Q2 | $9.87M | Sell |
362,023
-23,680
| -6% | -$631K | ﹤0.01% | 2027 |
|
|
2018
Q1 | $8.63M | Sell |
385,703
-10,048
| -3% | -$239K | ﹤0.01% | 2057 |
|
|
2017
Q4 | $8.34M | Sell |
395,751
-48,067
| -11% | -$1.1M | ﹤0.01% | 2077 |
|
|
2017
Q3 | $11M | Buy |
443,818
+9,119
| +2% | +$201K | ﹤0.01% | 1941 |
|
|
2017
Q2 | $8.43M | Buy |
434,699
+46,967
| +12% | +$852K | ﹤0.01% | 2069 |
|
|
2017
Q1 | $7.16M | Sell |
387,732
-4,559
| -1% | -$89.2K | ﹤0.01% | 2149 |
|
|
2016
Q4 | $7.43M | Sell |
392,291
-22,216
| -5% | -$454K | ﹤0.01% | 2121 |
|
|
2016
Q3 | $9.28M | Sell |
414,507
-108,199
| -21% | -$2.06M | ﹤0.01% | 1918 |
|
|
2016
Q2 | $9.31M | Sell |
522,706
-16,188
| -3% | -$262K | ﹤0.01% | 1892 |
|
|
2016
Q1 | $7.36M | Buy |
538,894
+32,751
| +6% | +$497K | ﹤0.01% | 1989 |
|
|
2015
Q4 | $9.76M | Buy |
506,143
+81,270
| +19% | +$1.62M | ﹤0.01% | 1856 |
|
|
2015
Q3 | $8.61M | Sell |
424,873
-29,862
| -7% | -$885K | ﹤0.01% | 1945 |
|
|
2015
Q2 | $15.1M | Buy |
454,735
+331,392
| +269% | +$9.08M | ﹤0.01% | 1690 |
|
|
2015
Q1 | $2.96M | Buy |
123,343
+22,317
| +22% | +$340K | ﹤0.01% | 2610 |
|
|
2014
Q4 | $1.24M | Sell |
101,026
-1,081
| -1% | -$11.2K | ﹤0.01% | 3167 |
|
|
2014
Q3 | $921K | Buy |
102,107
+21,992
| +27% | +$259K | ﹤0.01% | 3341 |
|
|
2014
Q2 | $941K | Buy |
80,115
+28,325
| +55% | +$384K | ﹤0.01% | 3348 |
|
|
2014
Q1 | $1.1M | Buy |
+51,790
| New | +$796K | ﹤0.01% | 3226 |
|
Other funds holding TVTX
VCM
SIMG
EA
VPM
Bank of New York Mellon's TVTX Position: Q2 2026 in Review
Bank of New York Mellon increased its Travere Therapeutics (TVTX) stake by 13% in Q2 2026, buying an estimated $1.3M and bringing the position to 246,485 shares worth $14M. The position accounts for ﹤0.01% of the portfolio, ranked #1843.
Bank of New York Mellon first reported a position in TVTX in Q1 2014 and has held it in 50 quarters since. The position peaked at $15.1M in Q2 2015. 218 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- Bank of New York Mellon held 246,485 shares of Travere Therapeutics worth $14M as of Q2 2026.
- Bank of New York Mellon bought 29,259 Travere Therapeutics shares in Q2 2026, an estimated $1.3M.
- Travere Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1843 holding.
- Bank of New York Mellon first reported a position in Travere Therapeutics in Q1 2014 and has held it in 50 quarters since.
- Bank of New York Mellon's Travere Therapeutics position peaked at $15.1M in Q2 2015.
- 218 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.